Igc acquires exclusive rights for a potential alzheimer's drug development candidate

Bethesda, md.--(business wire)-- #igc--igc is excited to announce that one of its subsidiaries reached an ip license agreement for a potential alzheimer's drug development candidate.

IGC Ratings Summary

IGC Quant Ranking